Report copyright - Basilea Pharmaceutica Ltd. (BSLN.S) · Zevtera is the First Broad-Spectrum Anti-MRSA Cephalosporin Approved for Hospital and Community Acquired Pneumonia. With demonstrated efficacy
Please pass captcha verification before submit form